Beauty Launchpad Announces 30 Over 30 Winners for 2024
Beauty Launchpad
MAY 6, 2024
Congratulations to this year's winners of Beauty Launchpad's 30 Over 30 contest, sponsored by Denman Brush, spotlighting 30 stylists over 30 years of age.
Mon.May 06, 2024
89 
Not Just Panda Food: Why Bamboo Is The Next Big Thing In Korean Skincare
Beautiful With Brains - Ingredients
MAY 6, 2024
Curious about bamboo skincare? Me too. When you say bamboo, I think of cute pandas lazily munching on their leaves up in the Chinese mountains. So cute! But bamboo isn’t just food for pandas. If you’re into Korean skincare, you’ve probably noticed bamboo has found its way into your skincare stash, too. Bamboo water has […] The post Not Just Panda Food: Why Bamboo Is The Next Big Thing In Korean Skincare appeared first on Beautiful With Brains.
Join 5,000+
Insiders
Sign Up for our Newsletter
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Trending Sources
Melanoma Monday 2024: Advances in the Early Detection and Treatment of Melanoma Are Changing the Game
The Dermatology Digest
MAY 6, 2024
It’s Melanoma Monday, and TDD Editorial Advisory Board Member Vishal Patel, MD, an Associate Professor of Dermatology at the GW School of Medicine & Health Sciences and the Director of the Cutaneous Oncology Program at the GW Cancer Center in Washington, DC, highlights recent advances in diagnosing and treating melanoma, including the approval of the DermaSensor device for detection in the primary care setting and new evidence that neoadjuvant immunotherapy before surgery improves outc
Atlanta, GA – May 29-30 – Botulinum Toxin and Dermal Fillers Training Course
AAFE - American Academy of Facial Esthetics
MAY 6, 2024
Register today for Atlanta, GA - May 29-30 - Botulinum Toxin and Dermal Fillers Training Course
Find a school
Striving for Melanoma Advancements With the Melanoma Research Alliance
Dermatology Times
MAY 6, 2024
Marc Hurlbert, PhD, discusses how the Melanoma Research Alliance works with dermatology clinicians to provide fundings and resources for melanoma research.
Top 5 Beauty School Myths Debunked
The Studio Academy of Beauty
MAY 6, 2024
Beauty school isn’t for the weak, and beauty school students can make a huge difference in the world, just like other working professionals do. Despite common misconceptions about the field, the beauty industry is incredibly important because cosmetologists, hair stylists, nail technicians, and other professionals make people feel good about themselves.
Sign up to get articles personalized to your interests!
Esthetician Leadership Today brings together the best content for skin care professionals from the widest variety of industry thought leaders.
More Trending
Atlanta, GA – Jun. 26-27 – Botulinum Toxin and Dermal Fillers Training Course
AAFE - American Academy of Facial Esthetics
MAY 6, 2024
Register today for Atlanta, GA - Jun.
Tumor Diameter of Melanoma Demonstrates Statistically Significant Correlation With Survival
Dermatology Times
MAY 6, 2024
Researchers found that the diameter of cutaneous melanoma demonstrated a weak positive correlation with tumor thickness.
Meet Akela Douglass: Beauty Launchpad 30 Over 30 Winner for 2024
Beauty Launchpad
MAY 6, 2024
Akela Douglass (@akelashair) is the owner of Got Roots Color Bar in Sacramento, CA and a national educator.
QUIZ: Melanoma Classification and Staging
Dermatology Times
MAY 6, 2024
Click here to read more and answer our quiz questions in recognition of Skin Cancer Awareness Month and Melanoma Monday.
NCEA 2
.png)
News You Can Use: Dr. Reddy’s Laboratories Launch Doxycycline Capsules, 40mg in the U.S.
The Dermatology Digest
MAY 6, 2024
Dr. Reddy’s Laboratories Ltd. is launching of Doxycycline Capsules, 40mg in the U.S. market, a therapeutic generic equivalent of Oracea (Galderma) Capsules, 40 mg approved by the U.S. Food and Drug Administration (USFDA). Oracea is indicated for the treatment of only inflammatory lesions of rosacea in adult patients. Dr. Reddy’s Doxycycline Capsules, 40 mg, are supplied in bottle counts of 30.
SLIDESHOW: Showcasing Melanoma Research at the 56th Annual ACMS Meeting
Dermatology Times
MAY 6, 2024
Dozens of investigators shared findings to advance care in patients with melanoma during Mohs micrographic surgery.
AD Pipeline Watch: Inmagene’s Anti-OX40 Monoclonal Antibody Performs Well in Phase 2a AD Trial
The Dermatology Digest
MAY 6, 2024
Treatment with Inmagene Biopharmaceuticals’ anti-OX40 monoclonal antibodyled to “rapid, marked, and durable” improvements of skin signs in in a Phase 2a trial of patients with atopic dermatitis (AD) IMG-007 is a non-depleting anti-OX40 mAb, bioengineered to have a silenced antibody-dependent cellular cytotoxicity (ADCC) function and a prolonged half-life.
COMING SOON: Navigating Pregnancy Safety and Systemic Treatments in Atopic Dermatitis
Dermatology Times
MAY 6, 2024
Elizabeth Kiracofe, MD, provides a look at an upcoming DermView program that will explore systemic treatments for atopic dermatitis in the context of reproductive health, for patients during pregnancy, pre-pregnancy, postpartum, and breastfeeding.
NCEA 1
Let's personalize your content